Second Annual Global Champions of Change Competition Winner

MMS has just concluded its second annual Global Champions of Change Competition (G3C), where colleagues from all MMS regions submitted innovative ideas based on our tradition of providing high-quality, efficient services to our clients to help discover and market life-changing medicines to patients around the world.  

Innovation is not new to MMS, we have designed our culture from the beginning to constantly strive for new and better ways to produce quality with efficiency. The G3C competition was created two years ago as a formal way to spark the sharing of innovative ideas from colleagues throughout the entire organization in a competitive but fun environment.  

This year’s G3C winner is Amanda Beaster, Senior Manager of Regulatory Strategy, for her submission of a tool to address labeling deficiencies in the pharmaceutical industry.  

The second-place winners are Audelia Munguia, Director of Safety Risk Management; Susan Mitcheson, Senior Safety Writer; Jeff Wiese, Technical Manager of Safety Writing; and Katrina O’Connor, Senior Medical Writer, for their submission aimed to enhance efficiencies and quality in aggregate reports.  

Thirty-one teams entered this year’s competition, and five teams were chosen to proceed to the final presentation round, with our global colleagues voting for the winner. All 31 entries are evaluated and considered for future implementation.  

Other submissions included ideas that included automation, improving processes, data visualization, supporting rare diseases, improving quality, and concepts relating to MMS technologies such as our TrialAssure Transparency Suite and Datacise.  

MMS believes that innovation comes directly from our colleagues at every level of the organization because those working in our services lines daily see the best opportunities for improvement, and are encouraged to bring those ideas forward. That’s why we often say that “innovation is a company sport”. The G3C competition is not the only time our colleagues can bring innovative ideas forward, and MMS colleagues are encouraged to submit their ideas for improvement throughout the year.   

We are so proud of our colleagues and the effort, energy, and excitement they exhibited during this competition and through their work on a daily basis.  

By Jim Balcom, Director of Partnerships and IT Governance 

Learn more and explore MMS career opportunities here.  

Contact us to speak with Jim Balcom to learn more about innovation.  

Suggested For You

perspectives

November 21st, 2024

Essential Nonclinical Strategies for Cell and Gene Therapy (CGT) Success

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development

perspectives

October 15th, 2024

Putting the Action in Diversity Action Plans and the Real-Time Data Visualization Technology Needed to Ensure It Happens

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders